The Power of Collaboration
October 10, 2017
A look a Merck’s global network of M Lab™ Collaboration Centers
1 min read
September 2017
Welcome to the September issue of The Medicine Maker! This issue marks the magazine’s third anniversary since our release. Our cover features unites six industry gurus to discuss the impending US and EU deadlines for serialization compliance in the pharma industry. Upfront covers the landmark approval of Kymriah, how gold nanoparticles can bypass chemotherapy toxicity, and why drugs fail in clinical trials, or even post-approval. In NextGen, experts cover the challenges of manufacturing cell therapies, and why ex vivo screening could boost new drug development. Plus, we sit down with Abhijit Mukherjee from Dr Reddys to talk about the business of generics.
The Formulation Complex
September 20, 2017
Unravelling the challenges and trends in formulation best practice – and why lipids and softgels are leading the way.
1 min read
Manufacture
Regulation & Standards
Business & Trends
Facilities & Equipment
Technology & Manufacturing
Packaging
Serialization Blind Spots
September 20, 2017
With all the complications of serialization, it’s easy to overlook a few key areas.
1 min read
Manufacture
Regulation & Standards
Business & Trends
Facilities & Equipment
Technology & Manufacturing
Outsourcing
Packaging
What’s on the Box?
September 20, 2017
Serialization deadlines are nigh, but is the industry ready? We ask six track-and-trace gurus.
1 min read
Know Thy Raw Materials
September 20, 2017
We asked customers what they wanted from their cell culture media suppliers and the reply was, “understand your raw materials”. So nine years ago we set out to characterize and evaluate our raw materials – this is what we found…We asked customers what they wanted from their cell culture media suppliers and the reply was, “understand your raw materials”. So nine years ago we set out to characterize and evaluate our raw materials – this is what we found…
1 min read
Discovery & Development
Bioprocessing
Biopharma
Facilities & Equipment
Technology & Manufacturing
Outsourcing
Sponsored
Collaborating to Get Biopharma in the Fast Lane
September 20, 2017
Scaling up a bioprocess doesn’t need to be a headache – especially when there are firms out there that can lend a helping hand.
1 min read
The Small-Molecule Problem Solver
September 20, 2017
Today’s small molecules are increasingly complex, but generic producers must keep track of the trends – since today’s innovator drugs are tomorrow’s generic targets.
1 min read
Getting Personal with Oncology
September 20, 2017
Genomics offers much hope for cancer treatment, but we remain a long way from truly personalized medicine. Ex vivo screening will save lives, reduce unnecessary treatments and lead to the development of new drugs.
1 min read
Twenty-First Century Cell Therapy
September 20, 2017
Advanced medicines are full of promise, but also pitfalls – not least making sure that manufacturing costs don’t trump the reimbursement price.
1 min read
Champion of Generics
September 20, 2017
Sitting Down With... Abhijit Mukherjee, Chief Operating Officer at Dr. Reddy’s Laboratories, India.
1 min read
Cater to the Customer
September 20, 2017
Efficacious and safe drugs often don’t make it to market. But why? And what can you do about it?
1 min read
Business-in-Brief
September 20, 2017
Keeping close ties, locking-up loopholes, and calculating costs… What’s new for pharma in business?
1 min read
Bright Spark
September 20, 2017
Using electrochemistry to boost manufacturing and drug discovery
1 min read
Leaving on a Jet Plane
September 20, 2017
At the end of October, thousands of industry experts will flock to Germany for one of Europe’s largest pharma trade shows
1 min read
Making Therapeutic History
September 20, 2017
The wait is over: the FDA gives a ‘thumbs-up’ to the first CAR-T therapy
1 min read
The Golden Touch
September 20, 2017
Researchers move a step closer to improving the effectiveness of cancer drugs by “manufacturing” therapeutic compounds in-vivo using gold nanoparticle catalysts
1 min read
Out with the Old, in with the New?
September 20, 2017
Not quite. Tried and tested analytical approaches like ELISA aren’t going away in the world of bioprocessing, but modern techniques allow for real-time analysis. Together, they present an orthogonal approach.
1 min read
Don’t Touch That Data
September 20, 2017
Not everyone in your organization understands or cares about data integrity – but they should.
1 min read
Here’s to Shared Successes!
September 20, 2017
The Medicine Maker celebrates its third birthday – and the exciting changes shaping drug development
1 min read
